NCT01777243 2018-07-24A Study to Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic AmyloidosisGlaxoSmithKlinePhase 1 Completed25 enrolled
NCT01406314 2017-06-09SAP Depleter Dose Assessment Study in PatientsGlaxoSmithKlinePhase 1 Completed17 enrolled
NCT02953808 2017-01-19Phase 1 Study of GSK2315698 in Healthy Japanese SubjectsGlaxoSmithKlinePhase 1 Completed18 enrolled